Jazz Pharmaceuticals (JAZZ) Shareholder's Equity Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.56% |
| Dec 31, 2025 | 5.49% |
| Sep 30, 2025 | -5.08% |
| Jun 30, 2025 | -1.49% |
| Mar 31, 2025 | 12.94% |
| Dec 31, 2024 | 9.55% |
| Sep 30, 2024 | 19.54% |
| Jun 30, 2024 | 6.72% |
| Mar 31, 2024 | 10.84% |
| Dec 31, 2023 | 21.11% |
| Sep 30, 2023 | 27.11% |
| Jun 30, 2023 | 10.15% |
| Mar 31, 2023 | -7.58% |
| Dec 31, 2022 | -22.18% |
| Sep 30, 2022 | -30.30% |
| Jun 30, 2022 | -22.53% |
| Mar 31, 2022 | -4.98% |
| Dec 31, 2021 | 8.35% |
| Sep 30, 2021 | 16.62% |
| Jun 30, 2021 | 31.50% |
| Mar 31, 2021 | 35.22% |
| Dec 31, 2020 | 17.64% |
| Sep 30, 2020 | 10.57% |
| Jun 30, 2020 | 5.31% |
| Mar 31, 2020 | 2.86% |
| Dec 31, 2019 | 12.82% |
| Sep 30, 2019 | 0.89% |
| Jun 30, 2019 | 3.96% |
| Mar 31, 2019 | -2.01% |
| Dec 31, 2018 | 1.63% |
| Sep 30, 2018 | 22.60% |
| Jun 30, 2018 | 30.38% |
| Mar 31, 2018 | 40.45% |
| Dec 31, 2017 | 44.52% |
| Sep 30, 2017 | 34.84% |
| Jun 30, 2017 | 22.17% |
| Mar 31, 2017 | 16.10% |
| Dec 31, 2016 | 10.02% |
| Sep 30, 2016 | 17.13% |
| Jun 30, 2016 | 24.52% |
| Mar 31, 2016 | 30.92% |
| Dec 31, 2015 | 24.44% |
| Sep 30, 2015 | 16.62% |
| Jun 30, 2015 | 13.03% |
| Mar 31, 2015 | 3.07% |
| Dec 31, 2014 | 5.84% |
| Sep 30, 2014 | 7.79% |
| Jun 30, 2014 | 8.90% |
| Mar 31, 2014 | 9.00% |
| Dec 31, 2013 | 15.54% |
| Sep 30, 2013 | 40.36% |
| Jun 30, 2013 | 41.37% |
| Mar 31, 2013 | 48.61% |
| Dec 31, 2012 | 481.62% |
| Sep 30, 2012 | 526.97% |
| Jun 30, 2012 | 718.40% |
| Dec 31, 2011 | 531.04% |